PEP-1-CAT-Transduced Mesenchymal Stem Cells Acquire an Enhanced Viability and Promote Ischemia-Induced Angiogenesis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhang, Lei ^a   Dong, Xiao Wei ^a   Wang, Jia Ning ^a   Tang, Jun Ming ^a   Yang, Jian Ye ^a   Guo, Ling Yun ^a   Zheng, Fei ^a   Kong, Xia ^a   Huang, Yong Zhang ^a   Chen, Shi You ^b  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CATALASE; CD34 ANTIGEN; CD45 ANTIGEN; CELL PENETRATING PEPTIDE 1 CATALASE FUSION PROTEIN; HERMES ANTIGEN; HYBRID PROTEIN; LACTATE DEHYDROGENASE; LEPTIN RECEPTOR; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; SUPEROXIDE DISMUTASE; TESTIS DETERMINING FACTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FEMALE; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GRAFT SURVIVAL; IN VIVO STUDY; INTRACELLULAR SIGNALING; LEG ISCHEMIA; LIPID PEROXIDATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; STAINING; STEM CELL GENE THERAPY; UPREGULATION;

ANIMALS; APOPTOSIS; CATALASE; CELL SURVIVAL; HYDROGEN PEROXIDE; ISCHEMIA; L-LACTATE DEHYDROGENASE; LOWER EXTREMITY; MALE; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSDUCTION, GENETIC; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84871911312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052537     Document Type: Article

References (23)

1. Pittenger MF, Martin BJ, (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20.
2. Perin EC, (2006) Stem cell therapy for cardiovascular disease. Tex Heart Inst J 33: 204-208.
3. Tsai RY, Kittappa R, McKay RD, (2002) Plasticity, niches, and the use of stem cells. Dev Cell 2: 707-712.
4. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-98.
5. Dong X, Wang JN, Huang YZ, Guo LY, Kong X, (2007) Cell-penetrating peptide PEP-1-mediated transduction of enhanced green fluorescent protein into human umbilical vein endothelial cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 29: 93-97.
6. Zhang YE, Fu SZ, Li XQ, Chen P, Wang JL, et al. (2011) PEP-1-SOD1 protects brain from ischemic insult following asphyxial cardiac arrest in rats. Resuscitation 82: 1081-1086.
7. Huang GQ, Wang JN, Tang JM, Zhang L, Zheng F, et al. (2011) The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury. J Transl Med 21 9: 73.
8. Wei H, Li Z, Hu S, Chen X, Cong X, (2010) Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem 111: 967-978.
9. Bradford M, (1976) A rapid and sensitive method for the quantitation of microgram uantities utilizing the principle of protein-dye binding. Anal biochem 72: 248-254.
10. Mishra V, Baines M, Wenstone R, Shenkin A, (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42: 269-276.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
12. Foster KA, Galeffi F, Gerich FJ, Turner DA, Müller M, (2006) Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol 79: 136-171.
13. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, et al. (2001) Evidence that human cardiac myocytes divide after myocardial infarction.N Engl J Med. 344: 1750-1757.
14. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
15. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
16. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, et al. (2005) Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res 66: 543-551.
17. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, et al. (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921.
18. Reinlib L, Field L, (2000) Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation 101: E182-187.
19. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, et al. (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46: 1339-1350.
20. Geng YJ, (2003) Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 1010: 687-697.
21. Bao C, Guo J, Zheng M, Chen Y, Lin G, et al. (2010) Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection. Biochem Cell Biol 88: 629-634.
22. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201.
23. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.